The Patent Finder

Solace Pharmaceuticals UK Ltd.

Also on record
Records under this name other than patents Solace Pharmaceuticals UK Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Solace Pharmaceuticals UK Ltd.

PatentTitleStatus Expires Confidence
US 10,059,664Sepiapterin Reductase Inhibitors for the Treatment of Pain
Formerly held
Lapsed on the fee record
Ended Aug 28, 2022 · Medium confidence
Lapsed on the fee recordEnded Aug 28, 2022Medium confidence
US 9,169,234Sepiapterin reductase inhibitors for the treatment of pain
Lapsed on the fee record
Ended Oct 27, 2019 · From the USPTO record
Lapsed on the fee recordEnded Oct 27, 2019From the USPTO record
US 5,409,935Xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas
Term ended
Term ended no later than Apr 25, 2015 · Low confidence
Term endedTerm ended no later than Apr 25, 2015Low confidence
US 5,475,002Use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery
Term ended
Term ended no later than Dec 12, 2015 · Low confidence
Term endedTerm ended no later than Dec 12, 2015Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited